Saudi Arabia Blood-based Biomaker For Sports Medicine Market Size & Outlook
Saudi Arabia blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Saudi Arabia blood-based biomaker for sports medicine market highlights
- The Saudi Arabia blood-based biomaker for sports medicine market generated a revenue of USD 6.1 million in 2023 and is expected to reach USD 9.8 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 7% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 6.1 million |
| Market revenue in 2030 | USD 9.8 million |
| Growth rate | 7% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.9% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 6.7 million by 2030.
Ck was the largest segment with a revenue share of 18.03% in 2023. Horizon Databook has segmented the Saudi Arabia blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In Saudi Arabia, the prevalence of sports injuries is becoming a notable concern as more individuals participate in various sports. The increasing engagement in physical activities and competitive sports has highlighted the need for advanced solutions to manage and prevent injuries. According to a report published in June 2021 by the Journal of Nature and Science of Medicine, football was identified as the most common cause of sports-related injuries, accounting for 43.6% of the injury rate.
Blood-based biomarkers are emerging as crucial tools in this context, offering precise insights into injury severity and recovery processes. As the country increasingly invests in sports infrastructure and programs, integrating advanced medical technologies like blood-based biomarkers is becoming essential for enhancing athlete care and performance management. This trend reflects Saudi Arabia's commitment to improving sports health and ensuring that athletes receive top-tier medical support.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Saudi Arabia Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
